ATHA (Athira Pharma Corp) Multiplikator Forward P/S
Athira Pharma, Inc. (ATHA) is focusing on the expansion of phosphgonimetone to combat Alzheimer's disease. The GURU.Markets system displays the change in forward P/S, where the current parameter is . Automated molecule screening is accelerating scientific research, while emerging catalysts for the new pipeline, with past failures already priced in, create a foundation for potential growth.
Ringkesan rincian data analitis Athira Pharma, Inc. (ATHA)
- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Athira Pharma, Inc.|ATHA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal athira.com|ATHA - Gunggung utang perusahaan|Utang marang nilai buku Athira Pharma Inc|ATHA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Athira Pharma|Likuiditas cepet athira.com
- rincian asil keuangan lan kelipatan valuasi:
ATHA - Bathi perusahaan|Proyeksi bathi mangsa ngarep Athira Pharma, Inc.|ATHA - Koefisien rega marang bathi|Prakiraan rega marang bathi athira.com|ATHA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Athira Pharma|ATHA - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Athira Pharma|ATHA - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan athira.com|ATHA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Athira Pharma, Inc.
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:Athira (ATHA)
Professional capital evaluates Athira Pharma, Inc. (ATHA) through the lens of strategic pivot risks and the efficacy of second-generation molecule development. The forward P/S ratio compares the issuer's market value with expected revenue, allowing this chart to determine the asset's degree of overvaluation during the cost restructuring period, which is critical for minimizing long-term portfolio drawdowns.
Pesaing wigati
Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S denalitherapeutics.com (DNLI)|Multiplikator Forward P/S HRMY (Harmony Biosciences Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Biohaven (BHVN)|Amylyx Corp - Multiplikator Forward P/S|TRVI - Multiplikator Forward P/S|Praxis Precision Medicines Inc (PRAX) - Rasio rega marang prakiraan pendapatan|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CeriBell|Multiplikator Forward P/S Prothena Corporation plc|Rasio rega marang prakiraan pendapatan Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan omeros.com OMER|neurogene.com (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|acimmune.com - Multiplikator Forward P/S|Voyager Therapeutics Inc (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Corp (NMRA) - Rasio rega marang prakiraan pendapatan|Scilex Holding Company, Inc. (SCLX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TVGN|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alpha Cognition Inc. ACOG|Rasio rega marang prakiraan pendapatan cogrx.com (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake Inhibikase Therapeutics, Inc.|Multiplikator Forward P/S SAVA (Cassava Sciences Inc)|Multiplikator Forward P/S Assertio Holdings, Inc. ASRT|COYA - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Vistagen (VTGN)|OVID: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acumen Pharmaceuticals Inc. (ABOS)|Multiplikator forward rega marang pendapatan CRVO|Kapitalisasi marang prakiraan pendapatan ATHE (Alterity Therapeutics)|Rasio rega marang prakiraan pendapatan Clene Nanomedicine (CLNN)|PEPG (PepGen) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan RLMD|ANVS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grace Therapeutics Inc|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Klotho Neurosciences Inc (KLTO)|Rasio rega marang prakiraan pendapatan neurosense-tx.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Reviva Pharmaceuticals Holdings Inc. RVPH|Rasio rega marang prakiraan pendapatan MetaVia Inc. (MTVA)|Rasio kapitalisasi marang dodolan sing dikarepake NeurAxis Inc|Multiplikator Forward P/S HSDT (heliusmedical.com)|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Minerva Neurosciences Inc|ADXN: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|PTIX (Protagenic Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|Rasio kapitalisasi marang dodolan sing dikarepake Cortigent|Multiplikator Forward P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|Cara Therapeutics Inc. - Multiplikator Forward P/S|Chromocell Therapeutics (CHRO) - Multiplikator forward rega marang pendapatan|ELYM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator Forward P/S|Marinus - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S
